Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-23

Clinical Trial Update: Endocalyx in Treatment Resistent Hypertension [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial of Endocalyx for treatment-resistant hypertension that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endocalyx

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Treatment Resistant Hypertension | Phase 2 | Status: RECRUITING